This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Objective It is advised that patients engage in physical activity to enhance their quality of life and achieve better results. The purpose of the current study was to measure the efficacy of exercise on the physical ability, cardiacfunction and cardiopulmonary fitness of patients with AF.
Background Exercise training is commonly employed as a efficacious supplementary treatment for individuals suffering from heart failure, but the optimal exercise regimen is still controversial.
Cardiovascular diseases pose a major threat to human life, functional activity, and quality of life. Patients with cardiovascular disease are always at risk for adverse cardiac events, decreased physical activity, psychoemotional disturbances, and limited social participation due to their varying pathologies.
Conclusion Our results suggest that the combined application of QSYQ can further improve patients' cardiacfunction and exercise tolerance, improve their quality of life, and ultimately improve patients' prognosis with a favorable safety profile.
Perhaps more importantly , the HU6 group achieved a range of obesity and HF-related secondary endpoints, including exercise capacity, quality of life, body composition, cardiacfunction/structure, and cardiometabolic dysfunction markers (e.g.
This study sought to assess the impact of combining ticagrelor and metoprolol extended-release tablets on clinical prognosis and cardiacfunction in elderly ACS patients following percutaneous coronary intervention (PCI).MethodsFrom BackgroundAcute coronary syndrome (ACS) poses significant risks to older individuals.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
64 
Let's personalize your content